Virtu Financial LLC Syros Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.69 - $1.21 $476 - $836	-691 Reduced 5.52%	11,832 $11,000
Q1 2022 May 17, 2022	BUY	$1.02 - $3.8 $12,773 - $47,587	12,523 New	12,523 $15,000
Q4 2021 Feb 17, 2022	SELL	$3.26 - $4.66 $68,264 - $97,580	-20,940 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.08 - $5.66 $85,435 - $118,520	20,940 New	20,940 $94,000
Q2 2021 Sep 17, 2021	SELL	$5.01 - $7.48 $170,294 - $254,252	-33,991 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$7.19 - $14.95 $244,395 - $508,165	33,991 New	33,991 $254,000
Q1 2018 May 14, 2018	SELL	$9.47 - $12.98 $186,161 - $255,160	-19,658 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$8.45 - $17.48 $166,110 - $343,621	19,658	19,658 $191,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.86M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.